|
Sort By
Time | Code | Name
|
|
| Release Time |
Code |
Stock Name |
Document (Hide Headline) |
| 20/04/2026 14:34 |
02888 |
STANCHART |
Announcements and Notices
Director Declaration (159KB, PDF)
|
| 20/04/2026 12:08 |
02551 |
APT ELECTRONICS |
Announcements and Notices
VOLUNTARY ANNOUNCEMENT - PROPOSED FURTHER INCREASE IN SHAREHOLDING OF
H SHARES OF THE COMPANY BY THE CONTROLLING SHAREHOLDER
GROUP AND SENIOR MANAGEMENT (433KB, PDF)
|
| 20/04/2026 12:03 |
01308 |
SITC |
Announcements and Notices
UNAUDITED QUARTERLY OPERATING STATISTICS
FOR THE FIRST QUARTER ENDED 31 MARCH 2026 (65KB, PDF)
|
| 20/04/2026 12:01 |
00616 |
ASSET CHAIN |
Announcements and Notices
VOLUNTARY ANNOUNCEMENT - ENTERING INTO MEMORANDUM OF COOPERATION (66KB, PDF)
|
| 20/04/2026 12:01 |
00274 |
RA SILK ROAD |
Announcements and Notices - (Delay in Results Announcement/Suspension )
QUARTER UPDATE ON RESUMPTION AND CONTINUED SUSPENSION OF TRADING (381KB, PDF)
|
| 20/04/2026 12:01 |
02729 |
GALAXIS TECH |
Announcements and Notices
END OF STABILIZATION PERIOD,
NO STABILIZATION ACTIONS
AND LAPSE OF OVER-ALLOTMENT OPTION (101KB, PDF)
|
| 20/04/2026 12:00 |
00460 |
SIHUAN PHARM |
Announcements and Notices
VOLUNTARY ANNOUNCEMENT-RESULTS OF PHASE III CLINICAL DATA OF DIROZALKIB FOR THE FIRST-LINE TREATMENT OF ALK POSITIVE ADVANCED NSCLC PRESENTED AT THE 2026 AACR (467KB, PDF)
|
| 20/04/2026 10:36 |
00931 |
CHINA HK POWER |
Announcements and Notices
TRADING HALT (52KB, PDF)
|
| 20/04/2026 08:52 |
00931 |
CHINA HK POWER |
Announcements and Notices
EXCHANGE NOTICE - TRADING HALT (1KB, HTM)
|
| 20/04/2026 08:25 |
02076 |
BOSS ZHIPIN-W |
Next Day Disclosure Returns - (Share Buyback)
Next Day Disclosure Returns (91KB, PDF)
|
| 20/04/2026 08:11 |
02476 |
VGT |
Announcements and Notices
List of Directors and their Roles and Functions (68KB, PDF)
|
| 20/04/2026 08:08 |
02476 |
VGT |
Announcements and Notices
Terms of Reference of the Strategy and Investment Committee of the Board of Directors (38KB, PDF)
|
| 20/04/2026 08:04 |
02476 |
VGT |
Announcements and Notices
Terms of Reference for the Nomination Committee of the Board of Directors (39KB, PDF)
|
| 20/04/2026 08:02 |
02476 |
VGT |
Announcements and Notices
Terms of Reference for the Remuneration and Appraisal Committee of the Board of Directors (41KB, PDF)
|
| 20/04/2026 08:00 |
02616 |
CSTONE PHARMA-B |
Announcements and Notices
VOLUNTARY ANNOUNCEMENT - CSTONE PRESENTED PRECLINICAL DATA FOR THREE NOVEL OR DIFFERENTIATED ADCS AT AACR 2026, INCLUDING CS5007 (EGFR/HER3) (2778KB, PDF)
|
| 20/04/2026 07:59 |
02476 |
VGT |
Announcements and Notices
Terms of Reference for the Audit Committee of the Board of Directors (55KB, PDF)
|
| 20/04/2026 07:55 |
02476 |
VGT |
Constitutional Documents
Articles of Association (241KB, PDF)
|
| 20/04/2026 07:49 |
02423 |
BEKE-W |
Next Day Disclosure Returns - (Share Buyback)
Next Day Disclosure Return (88KB, PDF)
|
| 20/04/2026 07:30 |
02390 |
ZHIHU-W |
Next Day Disclosure Returns - (Share Buyback)
NEXT DAY DISCLOSURE RETURN (95KB, PDF)
|
| 20/04/2026 07:09 |
06855 |
ASCENTAGE-B |
Announcements and Notices
VOLUNTARY ANNOUNCEMENT -
ASCENTAGE PHARMA PRESENTS FOUR PROMISING PRECLINICAL
STUDIES DEMONSTRATING THE POTENTIAL OF COMBINATION
THERAPIES AT AMERICAN ASSOCIATION FOR CANCER RESEARCH
(AACR) 2026 ANNUAL MEETING (114KB, PDF)
|